Loading clinical trials...
Loading clinical trials...
e-Cigarettes: Formaldehyde DNA Adducts, Oxidative Damage, and Potential Toxicity and Carcinogenesis
Conditions
Locations
1
United States
University of Minnesota
Minneapolis, Minnesota, United States
Start Date
July 11, 2017
Primary Completion Date
June 1, 2021
Completion Date
June 1, 2021
Last Updated
November 9, 2022
NCT06372899
NCT07441928
NCT06264154
NCT07214168
NCT07322796
NCT07312552
Lead Sponsor
University of Minnesota
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions